Towards Healthcare
U.S. Compounding Pharmacy Market
Updated Date: 20 March 2026   |   Report Code: 6201
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

U.S. Compounding Pharmacy Market Revenue and Analysis (2026-2035)

According to forecasts, the U.S. compounding pharmacy market will grow from USD 6.98 billion in 2025 to USD 12.79 billion by 2035, with an expected CAGR of 6.24%. The rising incidence of chronic conditions like diabetes, arthritis, and cancer necessitates ongoing treatment regimens. Compounded medications offer flexibility in dosing and formulation, accommodating the complex needs of these patients.

Last Updated : 20 March 2026 Category: Pharmaceuticals Insight Code: 6201 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The U.S. compounding pharmacy market currently in 2025 records USD 6.98 billion and is anticipated to grow to USD 12.02 billion by 2034, advancing at a CAGR of 6.24% from 2024 to 2034.

Answer : The South U.S. is leading the U.S. compounding pharmacy market share by 30% due to the increasing demand for personalized medicines, rising investment & funding, and the presence of major key players.

Answer : Key trends include the growing need for biologics, advancements in manufacturing technology, and increasing collaborations.
Any Questions

Meet the Team

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology and healthcare services.

Learn more about Deepa Pandey

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar